Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jan 21, 2020; 26(3): 307-323
Published online Jan 21, 2020. doi: 10.3748/wjg.v26.i3.307
Table 2 Association between nucleotide excision repair polymorphisms and colorectal cancer risk in the validation stage1, n (%)
SNP genotypeNCBI RefCRCCONP valueOR (95%CI)
DDB2
rs2029298n = 849n = 849
GG32 (37.2)393 (46.3)385 (45.3)1 (Ref)
GA38 (44.2)359 (42.3)368 (43.3)0.6500.95 (0.78-1.17)
AA16 (18.6)97 (11.4)96 (11.3)0.9190.98 (0.72-1.35)
GA + AA vs GG0.6770.96 (0.79-1.16)
AA vs GA + GG0.9801.00 (0.74-1.36)
PHWE0.5840.570
ERCC1
rs11615n = 850n = 847
CC54 (62.8)518 (60.9)494 (58.3)1 (Ref)
CT24 (27.9)293 (34.5)305 (36.0)0.3550.91 (0.74-1.11)
TT8 (9.3)39 (4.6)48 (5.7)0.2480.77 (0.50-1.20)
CT + TT vs CC0.2440.89 (0.73-1.08)
TT vs CT + CC0.3210.80 (0.52-1.24)
PHWE0.2000.919
rs735482n = 836n = 838
CC18 (20.9)169 (20.2)168 (20.0)1 (Ref)
CA40 (46.5)405 (48.4)403 (48.1)0.9661.00 (0.77-1.28)
AA28 (32.6)262 (31.3)267 (31.9)0.8560.98 (0.74-1.28)
CA + AA vs CC0.9200.99 (0.78-1.26)
AA vs CA + CC0.8120.98 (0.79-1.20)
PHWE0.7520.477
ERCC2
rs1052555n = 852n = 851
CCNA767 (90.0)759 (89.2)1 (Ref)
CTNA84 (9.9)91 (10.7)0.6050.92 (0.67-1.26)
TTNA1 (0.1)1 (0.1)0.9700.95 (0.06-15.21)
CT + TT vs CC0.6020.92 (0.67-1.26)
TT vs CT + CC0.9710.95 (0.06-15.22)
PHWENA0.307
rs50871n = 838n = 845
TT40 (46.5)429 (51.2)451 (53.4)1 (Ref)
TG36 (41.9)337 (40.2)358 (42.4)0.9220.99 (0.81-1.21)
GG10 (11.6)72 (8.6)36 (4.3)0.0012.09 (1.37-3.19)
TG + GG vs TT0.3741.09 (0.90-1.32)
GG vs TG + TT< 0.0012.08 (1.38-3.15)
PHWE1.0000.001
ERCC5
rs1047768n = 839n = 845
CC8 (9.3)75 (8.9)71 (8.4)1 (Ref)
CT30 (34.9)348 (41.5)351 (41.5)0.7350.94 (0.66-1.35)
TT48 (55.8)416 (49.6)423 (50.1)0.7080.94 (0.66-1.33)
CT + TT vs CC0.7170.94 (0.67-1.32)
TT vs CT + CC0.8220.98 (0.81-1.19)
PHWE0.4800.880
rs2094258n = 843n = 841
GG38 (44.2)307 (36.4)326 (38.8)1 (Ref)
GA42 (48.8)409 (48.5)392 (46.6)0.3891.10 (0.89-1.35)
AA6 (7.0)127 (15.1)123 (14.6)0.6151.08 (0.80-1.45)
GA + AA vs GG0.3701.10 (0.90-1.33)
AA vs GA + GG0.8371.03 (0.79-1.35)
PHWE0.4030.770
rs2228959n = 841n = 851
CC74 (86.0)754 (89.7)782 (91.9)1 (Ref)
CA12 (14.0)83 (9.9)62 (7.3)0.0511.41 (1.00-1.99)
AA0 (0.0)4 (0.5)7 (0.8)0.4080.59 (0.17-2.04)
CA + AA vs CC0.0951.33 (0.95-1.85)
AA vs CA + CC0.3830.58 (0.17-1.98)
PHWE1.000< 0.001
rs2296147n = 844n = 847
TT52 (60.5)508 (60.2)517 (61.0)1 (Ref)
TC32 (37.2)294 (34.8)289 (34.1)0.6841.04 (0.85-1.28)
CC2 (2.3)42 (5.0)41 (4.8)0.9041.03 (0.66-1.61)
TC + CC vs TT0.6791.04 (0.86-1.27)
CC vs TC + TT0.9521.01 (0.65-1.58)
PHWE0.4390.940
rs873601n = 842n = 837
GG16 (18.6)230 (27.3)223 (26.6)1 (Ref)
GA48 (55.8)435 (51.7)413 (49.3)0.8071.03 (0.82-1.29)
AA22 (25.6)177 (21.0)201 (24.0)0.3100.87 (0.66-1.14)
GA + AA vs GG0.8490.98 (0.79-1.22)
AA vs GA + GG0.1550.85 (0.67-1.07)
PHWE0.4390.719
XPA
rs10817938n = 823n = 822
TT58 (67.4)511 (62.1)547 (66.5)1(Ref)
TC24 (27.9)259 (31.5)241 (29.3)0.2311.14 (0.92-1.41)
CC4 (4.7)53 (6.4)34 (4.1)0.0211.70 (1.08-2.66)
TC + CC vs TT0.0711.21 (0.98-1.48)
CC vs TC + TT0.0331.62 (1.04-2.52)
PHWE0.6550.257
rs3176629n = 847n = 852
CC68 (79.1)689 (81.3)706 (82.9)1 (Ref)
CT18 (20.9)151 (17.8)133 (15.6)0.2401.17 (0.90-1.51)
TT0 (0.0)7 (0.8)13 (1.5)0.2250.56 (0.22-1.42)
CT + TT vs CC0.3991.11 (0.87-1.43)
TT vs CT + CC0.2050.55 (0.22-1.39)
PHWE0.7520.024
XPC
rs2607775n = 840n = 850
CC76 (84.5)755 (89.9)792 (93.2)1(Ref)
CG12 (13.3)80 (9.5)56 (6.6)0.0271.49 (1.05-2.13)
GG2 (2.2)5 (0.6)2 (0.2)0.2192.81 (0.54-14.56)
CG + GG vs CC0.0161.54 (1.09-2.18)
GG vs CG + CC0.2382.69 (0.52-13.95)
PHWE0.2510.343